These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 20381619)
1. Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish. van Bebber F; Paquet D; Hruscha A; Schmid B; Haass C Neurobiol Dis; 2010 Sep; 39(3):265-71. PubMed ID: 20381619 [TBL] [Abstract][Full Text] [Related]
2. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo. Paquet D; Schmid B; Haass C Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336 [TBL] [Abstract][Full Text] [Related]
3. Transgenic zebrafish model of neurodegeneration. Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595 [TBL] [Abstract][Full Text] [Related]
4. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity. Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162 [TBL] [Abstract][Full Text] [Related]
6. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity. Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568 [TBL] [Abstract][Full Text] [Related]
7. Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila. Talmat-Amar Y; Arribat Y; Redt-Clouet C; Feuillette S; Bougé AL; Lecourtois M; Parmentier ML Hum Mol Genet; 2011 Oct; 20(19):3738-45. PubMed ID: 21705366 [TBL] [Abstract][Full Text] [Related]
8. Modulation of tau pathology in tau transgenic models. Brion JP; Ando K; Heraud C; Leroy K Biochem Soc Trans; 2010 Aug; 38(4):996-1000. PubMed ID: 20658992 [TBL] [Abstract][Full Text] [Related]
9. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies. Zilka N; Korenova M; Novak M Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406 [TBL] [Abstract][Full Text] [Related]
11. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies. Sorrentino G; Bonavita V Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468 [TBL] [Abstract][Full Text] [Related]
12. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038 [TBL] [Abstract][Full Text] [Related]
13. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. Cente M; Filipcik P; Pevalova M; Novak M Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690 [TBL] [Abstract][Full Text] [Related]
15. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation. Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373 [TBL] [Abstract][Full Text] [Related]
16. Interneuronal transfer of human tau between Lamprey central neurons in situ. Kim W; Lee S; Jung C; Ahmed A; Lee G; Hall GF J Alzheimers Dis; 2010; 19(2):647-64. PubMed ID: 20110609 [TBL] [Abstract][Full Text] [Related]
17. From tau phosphorylation to tau aggregation: what about neuronal death? Buée L; Troquier L; Burnouf S; Belarbi K; Van der Jeugd A; Ahmed T; Fernandez-Gomez F; Caillierez R; Grosjean ME; Begard S; Barbot B; Demeyer D; Obriot H; Brion I; Buée-Scherrer V; Maurage CA; Balschun D; D'hooge R; Hamdane M; Blum D; Sergeant N Biochem Soc Trans; 2010 Aug; 38(4):967-72. PubMed ID: 20658986 [TBL] [Abstract][Full Text] [Related]
18. The formation of tau pathological phospho-epitopes in the axon is prevented by the dephosphorylation of selective sites in primary hippocampal neurons over-expressing human tau. Bertrand J; Sénéchal P; Zummo-Soucy M; Plouffe V; Leclerc N J Neurochem; 2010 Sep; 114(5):1353-67. PubMed ID: 20550628 [TBL] [Abstract][Full Text] [Related]
19. Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy. Spires-Jones TL; Friedman T; Pitstick R; Polydoro M; Roe A; Carlson GA; Hyman BT Neurosci Lett; 2014 Mar; 562():63-8. PubMed ID: 24462887 [TBL] [Abstract][Full Text] [Related]
20. Methylene blue reduced abnormal tau accumulation in P301L tau transgenic mice. Hosokawa M; Arai T; Masuda-Suzukake M; Nonaka T; Yamashita M; Akiyama H; Hasegawa M PLoS One; 2012; 7(12):e52389. PubMed ID: 23285020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]